Treatment of intermittent claudication: cilostazol (Review)

P. Collins, Julie Brittenden

Research output: Contribution to journalArticle

Abstract

Intermittent claudication is a potentially disabling disorder that impairs quality of life and is a marker of underlying cardiovascular disease. Treatment involves secondary prevention and measures to improve walking. Cilostazol significantly increases walking distance and quality of life in claudicants.

Original languageEnglish
Pages (from-to)466-470
Number of pages4
JournalHospital Medicine
Volume65
Publication statusPublished - 2004

Keywords

  • PERIPHERAL ARTERIAL-DISEASE
  • QUALITY-OF-LIFE
  • CARDIOVASCULAR EVENTS
  • CONTROLLED TRIALS
  • VASCULAR-DISEASE
  • METAANALYSIS
  • WALKING
  • MULTICENTER
  • PREVENTION
  • MANAGEMENT

Cite this